阅读说明：本技术 用于细胞疗法的基于靶向性配体-有效负载的药物递送 (Targeted ligand-payload based drug delivery for cell therapy ) 是由 P.S.洛 M.斯里尼瓦萨劳 B.张 于 2018-02-17 设计创作，主要内容包括：本文中公开了提供细胞疗法的灵活微调的药物递送平台。特别地,将工程化融合蛋白与要被移植细胞内化的携带至少一种药物有效负载的高亲和力配体偶联,以观察或调节移植的细胞疗法效果。(Disclosed herein are drug delivery platforms that provide flexible fine-tuning of cell therapies. In particular, the engineered fusion proteins are coupled to high affinity ligands carrying at least one drug payload to be internalized by the transplanted cells to observe or modulate the effect of the transplanted cell therapy.)